¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Other specified disturbances of temperature regulation of newborn"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® basal body temperature ÇÑ±Û ±âÃÊü¿Â
¼³¸í   
  À½½Ä-¿îµ¿-Á¤½Å°¨µ¿ µî Ã¼¿Â¿¡ ¿µÇâÀ» ÁÙ ¸¸ÇÑ ¿©·¯ Á¶°ÇÀ» ÇÇÇÏ¿© ¸ö°ú ¸¶À½ÀÌ ¾ÈÁ¤µÇ¾úÀ» ¶§ Àé Ã¼¿Â, º¸Åë ¾ÆÄ§¿¡ ´«À» ¶á Á÷ÈÄ¿¡ Àç¸ç, ¿©¼ºÀÇ °æ¿ì ¿ù°æ Áֱ⿡ µû¶ó ´Þ¶óÁö¹Ç·Î ¼öÅ Á¶ÀýÀ̳ª ÀÚ±Ã, ³­¼ÒÀÇ º´ Áø´Ü¿¡ ÀÀ¿ëÇÑ´Ù. 6~8½Ã°£ÀÇ ¾ÈÁ¤µÈ ¼ö¸éÀ» ÃëÇÑ ÈÄ ¾ÆÄ§ ÀÏÂï ±ú¾î³ª, ÀáÀÚ¸®¿¡¼­ ³ª¿À±â Àü¿¡ Ã¼¿Â°è¸¦ ÀÔ¿¡ ¹°¾î¼­ ÃøÁ¤ÇÑ´Ù. ¹Ì¹¦ÇѠü¿ÂÀÇ Â÷À̸¦ ÃøÁ¤Çϴ °ÍÀ̹ǷΠ¿©¼ºÃ¼¿Â°è¸¦ »ç¿ëÇϴ °ÍÀÌ ÁÁ´Ù. ÀÌ ¿©¼ºÃ¼¿Â°èÀÇ ¼öÀº±¸ºÎ¸¦ ÇôÀÇ ¾Æ·§¸é¿¡ ³¢¿ì°í¼­ ÀÔÀ» °¡º±°Ô ´Ù¹°°í ¾à 5ºÐ µ¿¾È ÀÖ´Ù°¡ ÃøÁ¤Çϸ頵ȴÙ. Á¤»óÀûÀΠ±âÃÊü¿ÂÀº º¹ÀâÇÑ ¼ºÁÖ±âÀÇ º¯È­¸¦ º¸À̱⠶§¹®¿¡ ¿ù°æÁֱ⿡ °üÇÑ °¢Á¾ Áø´ÜÀ» ºñ·ÔÇÏ¿© ÀÓ½Å-À¯»ê-ÀÌ»óÀÓ½ÅÀÇ Áø´Ü°ú ¼öÅÂÁ¶Àý µî¿¡ ÀÀ¿ëÇϴ µî ¿©·¯ °¡Áö È¿°úÀûÀΠÀÚ·á°¡ µÈ´Ù.
¿µ¹® newborn infant ÇÑ±Û ½Å»ý¾Æ
¼³¸í   
  ºÐ¸¸ Á÷ÈĺÎÅÍ µ¶¸³µÈ ÀÚ±ÃÀÇ »ýȰÀ» ÇÒ ¼ö Àִ ´É·ÂÀ» È¹µæÇÒ ¶§±îÁöÀÇ ¾ÆÀÌ. ½Å»ý¾Æ´Â »ýÈÄ 4ÁÖÀϱîÁö¸¦ ¸»ÇÑ´Ù. ÀÌ ±â°£¿¡ ½Å»ý¾Æ´Â ¸ðüÀÇ Å ¾È¿¡¼­ ÀÚµ¿ÀûÀ¸·Î »ê¼Ò³ª ¿µ¾çÀ» ¹Þ°í ÀÖ´ø »óÅ¿¡¼­ ÀÚ·ÂÀ¸·Î È£ÈíÀ̳ª ¿µ¾ç ¼·Ã븦 ÇϰԠµÇ´Â ±Þ°ÝÇÑ º¯È­°¡ ÀϾ°í, ÀÌ¿¡ µû¶ó¼­ ÃʱâÀǠü¿ÂÀÇ °­ÇÏ, »ý¸®Àû Ã¼ÁßÀÇ °¨¼Ò, ½Å»ý¾ÆÈ²´Þ, ÅÈÁÙÀÇ Å»¶ô µîÀÇ ¿©·¯ Çö»óÀÌ ÀϾ´Ù. °¨°¢¸é¿¡¼­´Â ¿µ¾ç ¼·Ã븦 À§ÇÑ ÈíÀιݻç´Â Àß ¹ß´ÞµÇ¾î ÀÖÀ¸³ª, ¹Ì°¢Àº ´ë°­ÀÇ ¸ÀÀÇ ÆÇº°, Èİ¢Àº °­ÇÑ ¾ÇÃë¿¡ ´ëÇÑ ¹ÝÀÀ, ½Ã°¢Àº ¸í¾ÏÀ» ÆÇº°Çϴ Á¤µµÀ̸ç, Ã»°¢Àº »ýÈÄ 1ÁÖÀϰæ±îÁö´Â °ÅÀÇ ¹ÝÀÀÀ» ³ªÅ¸³»Áö ¾Ê´Â´Ù.
¿µ¹® hemolytic disease of newborn ÇÑ±Û ½Å»ý¾Æ¿ëÇ÷º´
¼³¸í   
  ½Å»ý¾Æ¿¡¼­ ÀûÇ÷±¸°¡ ºñÁ¤»óÀûÀ¸·Î ¸¹ÀÌ ÆÄ±«µÇ´Â º´À¸·Î Å¾ÆÀû¸ð±¸Áõ(erythroblastosis fetalis)¿Í °°Àº ¶æÀ¸·Î ¾²ÀδÙ. À̰ÍÀº ¾î¸Ó´Ï¿¡°Ô¼­ »ý»êµÈ ½Å»ý¾Æ³ª Å¾ÆÀÇ ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ Å¹ÝÀ» °Ç³Ê¿Í¼­ Å¾ÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÇÏ¿©¼­ »ý±â´Â ¿ëÇ÷¼ººóÇ÷À» À̸£´Â ¸». ÁŻý¾Æ³ª Å¾ÆÀÇ ÀûÇ÷±¸ÀÇ Ç×ü°¡ ¾î¸Ó´ÏÀÇ ¸ö¿¡¼­ »ý»êÀÌ µÇ°í À̰ÍÀ̠ŹÝÀ» ÅëÇØ¼­ Å¾ƿ¡°Ô ³Ñ¾î°¡¼­ Å¾ÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÀ» Çϰí ÀÌ Ç×ü¿Í °áÇÕÇÑ ÀûÇ÷±¸´Â ÆÄ±«°¡ µÇ¾î¼­ ºóÇ÷ÀÌ »ý±ä °ÍÀ» Å¾ÆÀû¸ð±¸ÁõÀ̶ó°í ÇÑ´Ù. À̰ÍÀº Rh Àû¸ð±¸Áõ(Rh erythroblastosis)¿Í ABO Àû¸ð±¸Áõ(ABO erythroblastosis)·Î ³ª´­ ¼ö°¡ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • newborn
    ½Å»ý¾Æ
  • newborn baby
    ½Å»ý¾Æ
  • newborn behavior assessment scale
    ½Å»ý¾ÆÇൿÆò°¡Ã´µµ
  • newborn infant
    ½Å»ý¾Æ
  • down regulation
    ÇÏÇâÁ¶Àý
  • gene regulation
    À¯ÀüÀÚÁ¶Àý
  • genetic regulation
    À¯ÀüÀûÁ¶Àý
  • global regulation
    Åë°ýÁ¶Àý
  • humoral regulation
    ü¾×Á¶Àý
  • ionic regulation
    ÀÌ¿ÂÁ¶Àý
  • metabolic regulation
    ´ë»çÁ¶Àý
  • osmotic regulation
    »ïÅõ¾ÐÁ¶Àý
  • regulation
    1. ±ÔÁ¤ 2. Á¶Àý
  • up-regulation
    »óÇâÁ¶Àý
  • axillary temperature
    °Üµå¶ûü¿Â, ¾×¿Íü¿Â
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • newborn
    ½Å»ý¾Æ
  • regulation
    ±ÔÁ¤, Á¶Àý
  • respiration regulation
    È£ÈíÁ¶Àý
  • self regulation
    ÀÚ°¡Á¶Àý
  • temperature
    ¿Âµµ
  • basal body temperature
    ±âÃÊü¿Â
  • body temperature
    ü¿Â
  • core temperature
    ½ÉºÎü¿Â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • temperature regulation
    ü¿ÂÁ¶Àý
  • newborn baby
    ½Å»ý¾Æ
  • newborn metabolic disturbance
    ½Å»ý¾Æ´ë»çÀå¾Ö
  • newborn infant
    ½Å»ý¾Æ
  • newborn
    ½Å»ý¾Æ
  • newborn behavior assessment scale
    ¿µ¾ÆÇൿÆò°¡Ã´µµ
  • down regulation
    ÇÏÇâÁ¶Àý
  • gene regulation
    À¯ÀüÀÚÁ¶Àý
  • genetic regulation
    À¯ÀüÀûÁ¶Àý
  • global regulation
    Åë°ýÁ¶Àý
  • heat regulation
    ¿­Á¶Àý
  • humoral regulation
    ü¾×Á¶Àý
  • ionic regulation
    ÀÌ¿ÂÁ¶Àý
  • metabolic regulation
    ´ë»çÁ¶Àý
  • osmotic regulation
    »ïÅõ¾ÐÁ¶Àý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • regulation of body temperature
    ü¿ÂÁ¶Àý(ô÷è®ðàï½).
  • ABO hemolytic disease of the newborn
    ½Å»ý¾Æ ABO ¿ëÇ÷¼ºÁúȯ
  • IRDNI=£¾idiopathic respiratory distress of the newborn infant
    ½Å»ý¾Æ Ư¹ß¼º È£Èí°ï¶õÁõ, À¯¸®Áú¸·Áõ.
  • hemolytic disease of fetus/newborn
    žÆ/½Å»ý¾Æ¿ëÇ÷¼º Áúȯ
  • hemolytic disease of newborn
    ½Å»ý¾Æ¿ëÇ÷¼º Áúȯ.
  • hemolytic disease of newborn
    ½Å»ý¾Æ ¿ëÇ÷¼º Áúȯ
  • hemolytic disease of newborn
    ½Å»ý¾Æ¿ëÇ÷¼º Áúȯ.
  • hemorrhagic disease of newborn
    ½Å»ý¾ÆÃâÇ÷(¼º) Áúȯ.
  • idiopathic respiratory distress of newborn infant =IRDNI
    ½Å»ý¾ÆÆ¯¹ß¼º È£Èí°ï¶õÁõ.
  • Glucostatic hypothesis, of appetite regulation
    Ç×´ç±â¼³(ù÷ÓØÐñæò), ½Ä¿åÁ¶Àý(ãÝé¯ðàï½)
  • genetic regulation
    À¯ÀüÀû Á¶Àý.
  • genetic regulation
    À¯ÀüÀûÁ¶Àý
  • global regulation
    Åë°ýÁ¶Àý
  • heat regulation
    ü¿Â(¿­)Á¶Àý(ô÷è®æððàï½).
  • regulation
    ±ÔÁ¤
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • specified disease
    ƯÁ¤µÈ Áúº´(÷åïÒ¡­òðÜ»), ƯÀÌÁúȯ(÷åì¶òðü´)
  • regulation of body temperature
    ü¿ÂÁ¶Àý(ô÷è®ðàï½).
  • temperature regulation
    ü¿ÂÁ¶Àý(ô÷è® ðàï½).
  • atypical, mixed or other personality
    ºñÁ¤Çü ³»Áö È¥ÀçÇü ¶Ç´Â ±âŸ ÀΰÝ
  • shock and other somatic treatment
    Ãæ°Ý ¹× ±âŸ ½Åüġ·á
  • disturbances of urination
    ¹è´¢Àå¾Ö(ÛÉèñî¡äô).
  • menstruation disturbances
    ¿ù°æÀå¾Ö(êÅÌèî¡äô).
  • oral neurologic disturbances
    ±¸°­½Å°æÀå¾Ö(¡­ãêÌèî¡äô).
  • perceptual disturbances
    Áö°¢ ÀåÇØ
  • down regulation
    ÇÏÇâÁ¶Àý
  • down-regulation (of receptors)
    (¼ö¿ëü)ÇÏÇâÁ¶Àý.
  • down-regulation (of receptors)
    ¼ö¿ëü(áôé»ô÷)ÇÏÇâÁ¶Àý(ù»ú¾ðàï½).
  • gene regulation
    À¯ÀüÀÚÁ¶Àý(ðàï½).
  • gene regulation
    À¯ÀüÀÚÁ¶Àý.
  • genetic regulation
    À¯ÀüÀûÁ¶Àý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • coordinate regulation
    "µ¿Á¶Á¶Á¤(ÔÒðàðàïÚ), (ÔÒ) coordinate induction, coordinate"
  • down regulation
    ÇÏÇâ Á¶Àý(ù»ú¾ðàï½)
  • negative regulation
    À½Á¶Àý(ëäðàï½)
  • positive regulation
    "°¡Á¶Àý(ʦðàï½), ¾ç±ØÁ¶Àý(åÕпðàï½)"
  • receptor down regulation
    ¼ö¿ëü ÇÏÇâ Á¶Àý(áôé»ô÷ù»ú¾ðàï½)
  • absolute temperature
    Àý´ë¿Âµµ (ï¾Óßè®Óø)
  • critical temperature
    ÀÓ°è ¿Âµµ(×üÍ£è®Óø)
  • high-temperature protection regulon
    °í¿Âº¸È£(ÍÔè®ÜÁûÞ) ·¹±Ö·Ð
  • high-temperature-short-time method
    °í¿Â ´Ü½Ã°£¹ý(ÍÔè®Ó­ãÁÊàÛö)
  • Kelvin temperature scale
    Ä̺ó¿Âµµ(è®Óø) ´«±Ý
  • Krafft temperature
    Å©¶óÇÁÆ®¿Âµµ(è®Óø)
  • low-temperature heat method
    Àú¿Â¿­¹ý(î¸è®æðÛö)
  • melting temperature
    À¶Çؿµµ(ë×ú°è®Óø)
  • optimum temperature
    ÃÖÀû¿Âµµ(õÌîêè®Óø)
  • solid substrate room temperature phosphorescence
    °íü±âÁú ½Ç¿ÂÀα¤¹ý(ͳô÷Ðñòõ ãøè®ìÝÎÃÛö)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • regulation
    ±ÔÁ¤, Á¶Á¤, Á¶Àý
  • absolute temperature
    Àý´ë¿Âµµ
  • Curie temperature
    Å¥¸®¿Âµµ
  • newborn
    ½Å»ýÀÇ, ½Å»ý¾ÆÀÇ, ½Å»ý¾Æ
  • newborn infant
    ½Å»ý¾Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
FAR Federal acquisitions regulation; fractional albumin rate; fresh bone marrow
FR failure rate; film-screen radiograph; fasciculus retroflexus; febrile reaction; feedback regulation;...
IRIS integrated risk information system; interleukin regulation of immune system; International Research ...
ad add [Lat. adde] let there be added [up to a specified amount] [Lat. addetur]; axiodistal; right ear ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EDNOS Eating Disorder Not Otherwise Specified
NOS Not Otherwise Specified
PDD-NOS Pervasive Developmental Disorder Not Otherwise Specified
SPF specified pathogen free
DRO Differential Reinforcement of Other Behaviour
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • P81.8
    Other specified disturbances of temperature regulation of newborn
    ±âŸ ¸í½ÃµÈ ½Å»ý¾ÆÀÇ Ã¼¿Â Á¶Àý Àå¾Ö
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • regulation of body temperature
    ü¿Â Á¶Àý
  • disturbances of the sense of taste
    ¹Ì°¢ Àå¾Ö
    ¹Ì·Ú ³» ¼ö¿ë±â ¼¼Æ÷¿¡ ¹Ì°¢¿øÀÇ Á¢±ÙÀ» ¹æÇØÇϰųª, ¼ö¿ë±â ¼¼Æ÷°¡ ¼Õ»óµÇ°Å³ª ¶Ç´Â ¹Ì°¢ ±¸½É¼º ½Å°æ°ú ÁßÃß ¹Ì°¢·Î¸¦ ¼Õ»ó½ÃŰ´Â Á¶°Çµé¿¡ ÀÇÇÑ´Ù.
  • sleep disturbances
    ¼ö¸é Àå¾Ö
  • epidemic diarrhea of the newborn
    ½Å»ý¾Æ À¯Ç༺ ¼³»çÁõ
  • newborn infant
    ½Å»ý¾Æ
  • period of newborn
    ½Å»ý¾Æ±â
  • form-other
    Çü½Ä»óÀÇ ¸ñ
  • other abnormality
    ±âŸ ÀÌ»ó
  • other craniofacial disorder
    ´Ù¸¥ µÎ°³ ¾È¸é Àå¾Ö
  • other facial structure
    ´Ù¸¥ ¾È¸é ±¸Á¶¹°
  • other mycoses
    ±âŸ Áø±ÕÁõ
  • appetite regulation
    ½Ä¿å Á¶Àý
  • down regulation
    ÇÏÇâ Á¶Àý
    È£¸£¸óÀÇ ÀÛ¿ë ±âÀü¿¡¼­´Â È£¸£¸óÀÇ ³óµµ°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇØ ÀÖÀ¸¸é Ç¥Àû ¼¼Æ÷´Â ¼ö¿ëüÀÇ ¼ö¸¦ °¨¼Ò½ÃŰ´Â ¹ÝÀÀÀ» ÇÏ¸ç ±× °á°ú È£¸£¸óÀÇ °¨¼ö¼ºÀÌ °¨¼ÒÇÏ°Ô µÇ´Âµ¥ À̸¦ ÇÏÇâ Á¶ÀýÀ̶ó°í ÇÑ´Ù.
  • down-regulation of receptor
    ¼ö¿ëü ÇÏÇâ Á¶Àý
  • feedback regulation
    ÇÇÀ̵å¹é ¾ïÁ¦
    Ç×ü°¡ Á¸ÀçÇÔÀ¸·Î½á ±× Ç×ü¿¡ ÀÇÇÑ negativeÀÇ ±â±¸°¡ À¯µµµÇ¾î °°Àº ƯÀ̼ºÀ» °¡Áø Ç×ü »ý»êÀÌ ¾ïÁ¦µÇ´Â Çö»ó.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
other-directed Pertaining to a person readily influenced by the attitudes of others.
(05 Mar 2000)
transferases (other substituted phosphate groups) <enzyme> A class of enzymes that transfers substituted phosphate groups.
Registry number: EC 2.7.8
(12 Dec 1998)
ABO haemolytic disease of the newborn Erythroblastosis foetalis due to maternal-foetal incompatibility with respect to an antigen of the ABO blood group; the foetus possesses A or B antigen which is lacking in the mother, and the mother produces immune antibody which causes haemolysis of foetal erythrocytes.
(05 Mar 2000)
bullous impetigo of newborn Usually, widely disseminated bullous lesions appearing soon after birth, caused by infection with Staphylococcus aureus.
Synonym: impetigo neonatorum, pemphigus gangrenosus.
(05 Mar 2000)
respiratory distress syndrome of the newborn A disease seen especially in premature neonates with respiratory distress; characterised postmortem by atelectasis and alveolar ducts lined by an eosinophilic membrane; also associated with reduced amounts of lung surfactant.
Synonym: hyaline membrane syndrome, respiratory distress syndrome of the newborn.
(05 Mar 2000)
pleural effusion in newborn <radiology> Chylothorax most common cause of large effusion, erythroblastosis foetalis, Turner syndrome, congestive heart failure, infantile polycystic kidneys, wet-lung disease, hypervolaemia (idiopathic or iatrogenic), oesophageal tear, enteric cyst, obstructed pulmonary veins
(12 Dec 1998)
congenital epulis of newborn A congenital benign nodular tumour of the alveolar ridge, of unknown histogenesis; histologically, it is composed of large cells with a granular cytoplasm similar to that of a granular cell tumour (myoblastoma).
(05 Mar 2000)
postnatal pit of the newborn It marks the site where the embryonic spinal cord attaches to the skin.
Synonym: postnatal pit of the newborn.
(05 Mar 2000)
haemolytic anaemia of newborn <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells).
Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia.
(27 Sep 1997)
haemolytic disease of newborn <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells).
Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia.
(27 Sep 1997)
haemolytic disease of the newborn Abnormal breakup of red blood cells in the foetus or newborn. This is usually due to antibodies made by the mother directed against the baby's red cells. It is typically caused by rh incompatibility, that is differences between the mother and baby uinvolving the rh blood group.
(12 Dec 1998)
haemorrhagic disease of newborn A self-limited haemorrhagic disorder of the first days of life, caused by a deficiency of the vitamin k-dependent blood coagulation factors II, vii, ix, and x.
(12 Dec 1998)
haemorrhagic disease of the newborn A syndrome characterised by spontaneous internal or external bleeding accompanied by hypoprothrombinaemia, slightly decreased platelets, and markedly elevated bleeding and clotting times, usually occurring between the third and sixth days of life and effectively treated with vitamin K.
(05 Mar 2000)
hyaline membrane disease of the newborn A disease seen especially in premature neonates with respiratory distress; characterised postmortem by atelectasis and alveolar ducts lined by an eosinophilic membrane; also associated with reduced amounts of lung surfactant.
Synonym: hyaline membrane syndrome, respiratory distress syndrome of the newborn.
(05 Mar 2000)
spontaneous gangrene of newborn Gangrene due to vascular occlusion of unknown cause, usually in marasmic or dehydrated infants.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • newborn
    °«³­
  • newborn
    °«(¹æ±Ý)ž;½Å»ýÀÇ;´Ù½Ã ž;¸¶À½À» °íÃĸÔÀº;ºÎȰÇÑ;½Å»ý¾Æ \
  • regulation
    ±ÔÁ¤; Á¶Àý; ±ÔÁ¦; ÅëÁ¦
  • regulation
    ´Ü¼Ó;±ÔÁ¦;Á¶Àý;Á¶Á¤;±ÔÄ¢;±ÔÁ¤;¹ý±Ô;Á¤±ÔÀÇ;±ÔÁ¤ÀÇ;Ç¥ÁØÀÇ;Á¤»óÀÇ;º¸ÅëÀÇ;¿¹ÀÇ;¿©´À
  • regulation mourning
    Á¤½Ä »ó 
  • regulation speed
    ±ÔÁ¤(¹ýÁ¤) ¼Óµµ
  • temperature
    ¿Âµµ
  • Curie point (temperature)
    Äû¸®Á¡(¿Âµµ)(Àڱ⠺¯Å°¡ ÀϾ´Â ¿Âµµ)
  • absolute temperature
    Àý´ë ¿Âµµ
  • color temperature
    »ö¿Âµµ
  • critical temperature
    ÀÓ°è ¿Âµµ
  • normal temperature
    Æò»óü¿Â
  • room temperature
    (Åë»óÀÇ)½Ç³» ¿Âµµ(20µµÁ¤µµ)
  • temperature
    ¿Âµµ;ü¿Â;run a ~ ¿­ÀÌ ÀÖ´Ù;¿­À» ³»´Ù;ÈïºÐÇÏ´Ù;take one's ~ ü¿ÂÀ» Àç´Ù
  • each other
    ¼­·Î
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á